Levmentin

Levmentin is a marketed intravenous antibiotic combination developed by Delbert Pharma, consisting of amoxicillin, a beta-lactam antibiotic, and clavulanic acid, a beta-lactamase inhibitor. It is primarily indicated for the treatment of severe bacterial infections, including those in the respiratory tract and pneumology. Amoxicillin works by inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), while clavulanic acid protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant bacteria. Delbert Pharma specializes in maintaining essential medicines, and Levmentin is provided as a powder for solution for injection or infusion in various dosage strengths.

Brand names

Levmentin

Other names

amoxicillin + clavulanic acid